Literature DB >> 2496655

Outer membrane alterations in multiresistant mutants of Pseudomonas aeruginosa selected by ciprofloxacin.

N J Legakis1, L S Tzouvelekis, A Makris, H Kotsifaki.   

Abstract

Spontaneous mutants of Pseudomonas aeruginosa selected by ciprofloxacin were studied for outer membrane alterations. Acquisition of ciprofloxacin resistance was at least partially related to defects in lipopolysaccharide synthesis. When ciprofloxacin resistance was combined with resistance to beta-lactams and aminoglycosides, several alterations in outer membrane proteins were noted.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2496655      PMCID： PMC171437          DOI： 10.1128/AAC.33.1.124

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  The nature of Pseudomonas aeruginosa strain PAO bacteriophage receptors.

Authors:  A M Kropinski; L Chan; K Jarrell; F H Milazzo
Journal:  Can J Microbiol       Date:  1977-06       Impact factor: 2.419

2.  Correlation between lipopolysaccharide structure and permeability resistance in beta-lactam-resistant Pseudomonas aeruginosa.

Authors:  A J Godfrey; L Hatlelid; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

3.  Structural alterations in the envelope of a gentamicin-resistant rough mutant of Pseudomonas aeruginosa.

Authors:  L Galbraith; S G Wilkinson; N J Legakis; V Genimata; T A Katsorchis; E T Rietschel
Journal:  Ann Microbiol (Paris)       Date:  1984 Sep-Oct

4.  Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors:  N X Chin; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

5.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

6.  In vitro activity of ciprofloxacin, norfloxacin and nalidixic acid.

Authors:  A Bauernfeind; C Petermüller
Journal:  Eur J Clin Microbiol       Date:  1983-04       Impact factor: 3.267

7.  Morphological heterogeneity among Salmonella lipopolysaccharide chemotypes in silver-stained polyacrylamide gels.

Authors:  P J Hitchcock; T M Brown
Journal:  J Bacteriol       Date:  1983-04       Impact factor: 3.490

8.  Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO.

Authors:  N J Robillard; A L Scarpa
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

9.  Emergence of resistance to beta-lactam and aminoglycoside antibiotics during moxalactam therapy of Pseudomonas aeruginosa infections.

Authors:  L C Preheim; R G Penn; C C Sanders; R V Goering; D K Giger
Journal:  Antimicrob Agents Chemother       Date:  1982-12       Impact factor: 5.191

10.  Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa.

Authors:  L E Bryan; K O'Hara; S Wong
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191
View more
  31 in total

1.  Optimal use of antibiotics for intubation-associated pneumonia.

Authors:  J Rello; E Diaz
Journal:  Intensive Care Med       Date:  2001-02       Impact factor: 17.440

Review 2.  Efflux-mediated resistance to fluoroquinolones in gram-negative bacteria.

Authors:  K Poole
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

3.  A pleiotropic, posttherapy, enoxacin-resistant mutant of Pseudomonas aeruginosa.

Authors:  L J Piddock; M C Hall; F Bellido; M Bains; R E Hancock
Journal:  Antimicrob Agents Chemother       Date:  1992-05       Impact factor: 5.191

4.  Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors:  M Michea-Hamzehpour; C Lucain; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

5.  Persistence mechanisms in Pseudomonas aeruginosa from cystic fibrosis patients undergoing ciprofloxacin therapy.

Authors:  J M Diver; T Schollaardt; H R Rabin; C Thorson; L E Bryan
Journal:  Antimicrob Agents Chemother       Date:  1991-08       Impact factor: 5.191

6.  Conservation of the multidrug resistance efflux gene oprM in Pseudomonas aeruginosa.

Authors:  N Bianco; S Neshat; K Poole
Journal:  Antimicrob Agents Chemother       Date:  1997-04       Impact factor: 5.191

7.  Differential selection of multidrug efflux mutants by trovafloxacin and ciprofloxacin in an experimental model of Pseudomonas aeruginosa acute pneumonia in rats.

Authors:  O F Join-Lambert; M Michéa-Hamzehpour; T Köhler; F Chau; F Faurisson; S Dautrey; C Vissuzaine; C Carbon; J Pechère
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

8.  Factors influencing the accumulation of ciprofloxacin in Pseudomonas aeruginosa.

Authors:  R A Celesk; N J Robillard
Journal:  Antimicrob Agents Chemother       Date:  1989-11       Impact factor: 5.191

9.  Ciprofloxacin-induced, low-level resistance to structurally unrelated antibiotics in Pseudomonas aeruginosa and methicillin-resistant Staphylococcus aureus.

Authors:  J Fung-Tomc; B Kolek; D P Bonner
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

10.  Cell Envelope Changes in Solvent-Tolerant and Solvent-Sensitive Pseudomonas putida Strains following Exposure to o-Xylene.

Authors:  H C Pinkart; J W Wolfram; R Rogers; D C White
Journal:  Appl Environ Microbiol       Date:  1996-03       Impact factor: 4.792
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.